Tech Company Financing Transactions

Citius Pharmaceuticals Funding Round

On 3/7/2024, Citius Pharmaceuticals received $2.4 million in investment from New Jersey Economic Development Authority.

Transaction Overview

Announced On
3/7/2024
Transaction Type
Venture Equity
Amount
$2,400,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11 Commerce Dr. 1st Floor
Cranford, NJ 07016
USA
Email Address
Overview
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.
Profile
Citius Pharmaceuticals LinkedIn Company Profile
Social Media
Citius Pharmaceuticals Company Twitter Account
Company News
Citius Pharmaceuticals News
Facebook
Citius Pharmaceuticals on Facebook
YouTube
Citius Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Myron Holubiak
  Myron Holubiak LinkedIn Profile  Myron Holubiak Twitter Account  Myron Holubiak News  Myron Holubiak on Facebook
Chief Executive Officer
Leonard Mazur
  Leonard Mazur LinkedIn Profile  Leonard Mazur Twitter Account  Leonard Mazur News  Leonard Mazur on Facebook
Chief Financial Officer
Jaime Bartushak
  Jaime Bartushak LinkedIn Profile  Jaime Bartushak Twitter Account  Jaime Bartushak News  Jaime Bartushak on Facebook
Chief Medical Officer
Myron Czuczman
  Myron Czuczman LinkedIn Profile  Myron Czuczman Twitter Account  Myron Czuczman News  Myron Czuczman on Facebook
Vice President
Ilanit Allen
  Ilanit Allen LinkedIn Profile  Ilanit Allen Twitter Account  Ilanit Allen News  Ilanit Allen on Facebook
Vice President
John Westman
  John Westman LinkedIn Profile  John Westman Twitter Account  John Westman News  John Westman on Facebook
VP - Bus. Development
Paul Sowyrda
  Paul Sowyrda LinkedIn Profile  Paul Sowyrda Twitter Account  Paul Sowyrda News  Paul Sowyrda on Facebook
VP - Bus. Development
Jay Wadekar
  Jay Wadekar LinkedIn Profile  Jay Wadekar Twitter Account  Jay Wadekar News  Jay Wadekar on Facebook
VP - Manufacturing
Kelly Creighton
  Kelly Creighton LinkedIn Profile  Kelly Creighton Twitter Account  Kelly Creighton News  Kelly Creighton on Facebook
VP - Operations
Gary Talarico
  Gary Talarico LinkedIn Profile  Gary Talarico Twitter Account  Gary Talarico News  Gary Talarico on Facebook
VP - Regulatory Affairs
Alan Lader
  Alan Lader LinkedIn Profile  Alan Lader Twitter Account  Alan Lader News  Alan Lader on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/7/2024: Pro Shop venture capital transaction
Next: 3/7/2024: DevEngine venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary